바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.63 No.1
Citation Share

Treatment Results and Prognostic Factors of Complicated Parapneumonic Effusion and Empyema

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2007, v.63 no.1, pp.24-30









& (2007). Treatment Results and Prognostic Factors of Complicated Parapneumonic Effusion and Empyema. Tuberculosis & Respiratory Diseases, 63(1), 24-30.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: Pleural effusion develops in approximately 40% of pneumonia patients. In 5-10% of these cases, it progresses to complicated parapneumonic effusion (CPPE) or empyema that requires drainage. The prognostic factors of CPPE and empyema remain to be clarified. We examined the treatment outcomes of CPPE and empyema and elucidating their prognostic factors. Methods: One hundred and fifteen patients with CPPE or empyema, who were diagnosed and treated in Kyungpook National University Hospital (Daegu, Korea) between September 2001 and December 2005, were retrospectively analyzed. All the data was acquired from their chart review, and regarding treatment results, the time to defervescence and the length of hospital stay were analyzed. Results: The treatment was successful in 101 patients with a success rate of 87.8%. Multivariate analysis showed the level of pleural fluid lactate dehydrogenase (LDH) to be a significant prognostic factor (odds ratio [OR] 7.37; 95% confidence interval [CI], 1.63 to 33.37; p=0.009). Pussy pleural fluid (r=0.236; p=0.01) and the frequency of urokinase use (r=0.257; p=0.01) correlated with the time to defervescence. However, there was no clinical factor that correlated with the length of hospital stay. Conclusion: The pleural fluid LDH level is a useful prognostic factor for monitoring treatment results of CPPE and empyema. (Tuberc Respir Dis 2007; 63: 24-30)

keywords
Empyema, Lactate dehydrogenase, Pleural effusion, Pneumonia, Prognosis., Empyema, Lactate dehydrogenase, Pleural effusion, Pneumonia, Prognosis.

Reference

1.

(2006) Parapneumonic effusions and empyema,

2.

(1996) Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? ,

3.

Webb WR. Management of nontuberculous empyema a statement of the subcommittee on surgery. Am Rev Respir Dis 1962,

4.

(1997) Parapneumonic effusion and empyema,

5.

(2005) Percutaneous management of parapneumonic effusions,

6.

Empyema thoracis: medical aspects of evaluation and treatment,

7.

(1999) Prediction of outcome and long-term survival in patients with pleural infection,

8.

(2005) Factors influencing length of hospital stay in patients with bacterial pleural effusion,

9.

(2003) Prognostic features of residual pleural thickening in parapneumonic pleural effusions ,

10.

(1996) The effect of percutaneous pig-tail catheter drainage in the management of lung abscess and empyema ,

11.

(1996) The evaluation of image-guided catheter drainage in pleural effusion and empyema,

12.

(2003) Efficacy of pigtail catheter drainage in patients with thoracic empyema or complicated parapneumonic effusion,

13.

(2006.12.28.) Helping patients who drink too much. A clinician’s guide,

14.

(2005) Quantifying the risks associated with exceeding recommended drinking limits,

15.

based on European/North American multicenter study. JAMA 1993,

16.

Orringer MB. Modern management of adult thoracic empyema. J Thorac Cardiovasc Surg 1985,

17.

(1999) Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion or empyema,

18.

(2004) Intrapleural streptokinase for empyema and complicated parapneumonic effusions,

19.

(2000) Bronchial reactivity to cigarette smoke: relation to lung function, respiratory symptoms, serum-immunoglobulin E and blood eosinophil and leukocyte counts,

20.

(2006) Smoking and systemic disease,

21.

(1998) Prediction of clinical severity and outcome of ventilator-associated pneumonia,

22.

(2005) SAPS II revisited,

23.

(2006) Comparison of severity of illness scoring systems for patients with nosocomial blood stream infection due to Pseudomonas aerusinosa,

24.

(2000) A comparison of severity of illness scoring systems for elderly patients with severe pneumonia,

25.

(2005) Early use of intrapleural fibrinolytics in the management of postpneumonic empyema,

26.

(1997) Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study,

27.

(1996) Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy